Startup profile · funding coverage
Molagri funding, valuation and investors
Toronto biotech developing modular biological crop protection for specific insect pests.
Keep track of Molagri
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Pre-seed and seed — combined funding disclosure
$5.8M total across two stages; not additive to separately reported seed funding · October 14, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Toronto, Canada
Investors in latest funding
Lead: Convective Capital
Other: Y Combinator , Superorganism , Robinhood Ventures , Paul Graham , Julian Capital (earlier pre-seed lead)
Overview
Molagri develops precision biopesticides using engineered non-infectious virus-like particles. The company disclosed $5.8M in combined pre-seed and seed funding on October 14, 2026. Convective Capital led the seed; Julian Capital led the earlier pre-seed. Founders are Zaky Hassan and Min Jin. Source: https://molagri.com/blog/seed-round/
Why Molagri is interesting
The investment case is whether a targeted, adaptable platform can become an effective and economical field product. Commercial selectivity, manufacturing cost and the regulatory treatment of product changes remain key tests.
Product & use cases
A modular crop-protection platform intended to target particular pests. The first intended markets are tree nuts and tree fruits; commercial-field efficacy and selectivity are not established by the financing announcement.
Key facts
- $5.8M is a combined funding disclosure, not one newly closed seed round.
- BetaKit reports a $5.2M seed and approximately $0.6M raised earlier; the company release does not allocate the combined total.
- Proceeds support scientific hiring and R&D.
Funding history (newest first)
Pre-seed and seed — combined funding disclosure
2026-10-14 $5.8M total across two stages; not additive to separately reported seed funding- Convective Capital (lead)
- Y Combinator (participant)
- Superorganism (participant)
- Robinhood Ventures (participant)
- Paul Graham (participant)
- Julian Capital (earlier pre-seed lead) (participant)
Investors in our directory
Funds linked from Molagri's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Potential differentiation rests on species targeting and adaptability. Field performance, grower economics, scalable manufacturing and regulatory evidence are more useful milestones than treating laboratory targeting as a proven commercial advantage.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Molagri's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.